Literature DB >> 361566

Immunization of suckling pigs against enteric enterotoxigenic Escherichia coli infection by vaccinating dams with purified pili.

B Nagy, H W Moon, R E Isaacson, C C To, C C Brinton.   

Abstract

Pregnant swine (gilts) were vaccinated parenterally with a suspension of purified pili from the porcine enterotoxigenic Escherichia coli strain 987 (09:K103::NM). Gilts injected with placebo served as controls. Suckling pigs born to gilts in both groups were challenged intragastrically with virulent strain 987. The percentage of deaths, incidence and duration of diarrhea, numbers of E. coli in the ilea, and E. coli attachment to the villous epithelia were significantly less in suckling pigs of vaccinated gilts than in those of controls. These results are consistent with the hypothesis that pili of some enterotoxigenic E. coli facilitate adhesion to intestinal epithelia. Vaccination of dams with pili appears to be a means of immunizing against diarrheal disease caused by enterotoxigenic E. coli in suckling neonates. This work confirms the role of somatic pili as colonization and virulence factors and provides another example of safe and effective purified pilus vaccines.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361566      PMCID: PMC421985          DOI: 10.1128/iai.21.1.269-274.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  A NEW TYPE OF BACTERIAL PILUS GENETICALLY CONTROLLED BY THE FERTILITY FACTOR OF E. COLI K 12 AND ITS ROLE IN CHROMOSOME TRANSFER.

Authors:  C C BRINTON; P GEMSKI; J CARNAHAN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-09       Impact factor: 11.205

2.  Non-flagellar appendages of bacteria.

Authors:  C C BRINTON
Journal:  Nature       Date:  1959-03-21       Impact factor: 49.962

3.  Electrophoresis and phage susceptibility studies on a filament-producing variant of the E. coli B bacterium.

Authors:  C C BRINTON; A BUZZELL; M A LAUFFER
Journal:  Biochim Biophys Acta       Date:  1954-12

4.  Isolation and characterization of Escherichia coli phase variants and mutants deficient in type 1 pilus production.

Authors:  L M Swaney; Y P Liu; C M To; C C To; K Ippen-Ihler; C C Brinton
Journal:  J Bacteriol       Date:  1977-04       Impact factor: 3.490

5.  In vitro production and inactivation of Escherichia coli enterotoxin.

Authors:  S T Donta; H W Moon; S C Whipp; S M Skartvedt
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

6.  Protection against enteric disease caused by Escherichia coli--a model for vaccination with a virulence determinant?

Authors:  J M Rutter; G W Jones
Journal:  Nature       Date:  1973-04-20       Impact factor: 49.962

Review 7.  The properties of sex pili, the viral nature of "conjugal" genetic transfer systems, and some possible approaches to the control of bacterial drug resistance.

Authors:  C C Brinton
Journal:  CRC Crit Rev Microbiol       Date:  1971-05

8.  Colonization of porcine small intestine by Escherichia coli: colonization and adhesion factors of pig enteropathogens that lack K88.

Authors:  R E Isaacson; B Nagy; H W Moon
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

9.  Genetic complementation analysis of Escherichia coli type 1 somatic pilus mutants.

Authors:  L M Swaney; Y P Liu; K Ippen-Ihler; C C Brinton
Journal:  J Bacteriol       Date:  1977-04       Impact factor: 3.490

10.  Colonization of porcine intestine by enterotoxigenic Escherichia coli: selection of piliated forms in vivo, adhesion of piliated forms to epithelial cells in vitro, and incidence of a pilus antigen among porcine enteropathogenic E. coli.

Authors:  B Nagy; H W Moon; R E Isaacson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more
  55 in total

1.  Production of FaeG, the major subunit of K88 fimbriae, in transgenic tobacco plants and its immunogenicity in mice.

Authors:  Yahong Huang; Wanqi Liang; Aihu Pan; Zhiai Zhou; Cheng Huang; Jianxiu Chen; Dabing Zhang
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

2.  Nucleotide sequences of four variants of the K88 gene of porcine enterotoxigenic Escherichia coli.

Authors:  C W Dykes; I J Halliday; M J Read; A N Hobden; S Harford
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

3.  Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein.

Authors:  M S Hanson; J Hempel; C C Brinton
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

4.  Effect of parenteral vaccination of dams on intestinal Escherichia coli in piglets with diarrhea.

Authors:  O Söderlind; E Olsson; C J Smyth; R Möllby
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Genital antibody response to a parenteral gonococcal pilus vaccine.

Authors:  D McChesney; E C Tramont; J W Boslego; J Ciak; J Sadoff; C C Brinton
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Participation of pili and cell wall adhesion in the yeast agglutination activity of Escherichia coli.

Authors:  Y Eshdat; V Speth; K Jann
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  In vitro adhesion of piliated Escherichia coli to small intestinal villous epithelial cells from rabbits and the identification of a soluble 987P pilus receptor-containing fraction.

Authors:  E A Dean; R E Isaacson
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Escherichia coli 987P pilus: purification and partial characterization.

Authors:  R E Isaacson; P Richter
Journal:  J Bacteriol       Date:  1981-05       Impact factor: 3.490

9.  Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified K99 or 987P pili: antibody production in response to vaccination.

Authors:  R E Isaacson; E A Dean; R L Morgan; H W Moon
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Antipili antibody affords protection against experimental ascending pyelonephritis.

Authors:  F J Silverblatt; L S Cohen
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.